Domestic Manufacturing Revitalization Act of 2026
- Sponsor
- Sen. Cassidy, Bill [R-LA]
- Committees
- Finance Committee (primary)
- Last action
- Sep 24, 2026
Bottom line
The bill aims to boost domestic manufacturing and supply chain resilience for critical medical supplies through a combination of purchasing incentives for hospitals, import tariffs, and tax credits for producers.
What it actually does
This bill establishes a pilot program under Medicare to incentivize large hospitals to purchase domestic personal protective equipment (PPE) and medical consumables by offering reimbursements for domestic purchases and imposing payment reductions for non-compliance. It also significantly increases tariffs on imported medical supplies and creates new tax credits for domestic PPE production and manufacturing investments.
Proponents argue
Proponents argue this bill strengthens national security by reducing reliance on foreign supply chains for essential medical goods, particularly in light of past pandemic-related shortages. They contend it will create American jobs, foster innovation in domestic manufacturing, and ensure a stable supply of high-quality PPE and medical consumables for healthcare providers.
Opponents contend
Opponents might argue that the increased tariffs could raise healthcare costs for hospitals and ultimately for patients, potentially leading to shortages if domestic production cannot meet demand or if the quality of domestic products is not competitive. They may also raise concerns about potential trade disputes and the administrative burden on hospitals and manufacturers.
The bill is moderately complex, requiring careful reading of definitions and phased-in provisions, but is manageable for an informed reader.
Sec. 2, new Sec. 1866H(a) of Social Security Act
Establishment of Domestic Purchasing Incentive Pilot Program
This provision directs the Secretary of Health and Human Services to establish a pilot program within two years. The program's goal is to incentivize eligible hospitals to meet specific domestic purchasing requirements for personal protective equipment (PPE) and medical consumables.
Supporters argue
Proponents argue this provision creates a direct mechanism to encourage domestic sourcing, thereby addressing critical supply chain vulnerabilities identified during national emergencies.
Critics contend
Opponents might argue that establishing a new pilot program adds another layer of federal bureaucracy and potential administrative burdens for both the government and participating hospitals.
Tradeoffs
The provision balances the goal of increasing domestic sourcing with the need to create a manageable and effective federal program.
Sec. 2, new Sec. 1866H(b) of Social Security Act
Identification of Eligible Hospitals
This section defines 'eligible hospitals' as those identified by the Secretary of HHS for having received Medicare payments greater than the average amount over the preceding five years, provided they agree to the program's purchasing requirements. Other hospitals not meeting this threshold can voluntarily opt-in to participate.
Sec. 2, new Sec. 1866H(c) of Social Security Act
Domestic Purchasing Requirement and Attestation
Participating hospitals must ensure that at least 40% of their personal protective equipment and medical consumables are 'domestic products.' The Secretary can adjust this percentage during supply chain disruptions or emergencies. Manufacturers must annually attest under penalty of perjury that their products meet the domestic definition, and hospitals must submit this data as part of their cost reports.
Sec. 2, new Sec. 1866H(d) of Social Security Act
Penalties for Failing Domestic Purchasing Requirements
Starting after the third year of the program, hospitals that fail to meet the domestic purchasing requirement will face a decreased Medicare payment rate. This penalty escalates from 2% for one year of non-compliance to 8% for seven or more years of non-compliance. These payment reductions will remain in effect even after the program's termination.
Sec. 2, new Sec. 1866H(e) of Social Security Act
Reimbursement for Domestic Product Purchases
For each year of the program, participating hospitals will receive an annual reimbursement equal to the dollar amount of domestic PPE and medical consumables they purchased. These funds are drawn from additional duties collected from increased tariffs on imported medical supplies (as detailed in Section 3). Any remaining tariff funds after hospital reimbursements are transferred to the Federal Hospital Insurance Trust Fund.
Sec. 2, new Sec. 1866H(g) of Social Security Act
Override of Trade Agreements and Buy American Act
This provision explicitly states that the domestic purchasing requirements established by this section apply notwithstanding any conflicting requirements under the Government Procurement Agreement, other international trade agreements to which the United States is a party, or waivers under the 'Buy American Act' (Chapter 83 of Title 41, U.S. Code).
Sec. 3(a)-(b)
300% Ad Valorem Tariff on Covered Medical Articles
This section directs the President to revise the Harmonized Tariff Schedule of the United States to impose a 300% ad valorem duty on a list of 'covered articles,' which are specific medical supplies. This duty increase is phased in over five years, starting with 10% of the total increase after 180 days and reaching 100% of the increase after five years.
Sec. 3(c)
Funding Mechanism for Hospital Reimbursement
This provision mandates that, at least annually, the Secretary of the Treasury must transfer an amount equal to the additional duties collected from the increased tariff rates (established in Section 3(a)-(b)) to the Secretary of Health and Human Services. These transferred funds are specifically designated to finance the hospital reimbursement program outlined in Section 2.
Sec. 4(a), new Sec. 45BB of Internal Revenue Code
Personal Protective Equipment Production Credit
This section establishes a new general business tax credit for the production and sale of specific 'qualified personal protective equipment' (N95 masks, surgical masks, medical gloves, surgical gowns, ventilators, and other designated major equipment). The credit amounts vary by item, from $0.05 per glove to $250 per ventilator. To qualify, equipment must be produced in the United States and meet domestic content requirements (60% until 2028, then 75%). This credit terminates after December 31, 2035.
Sec. 4(b), new Sec. 48F of Internal Revenue Code
Investment Credit for PPE Manufacturing Property
This section creates a 20% investment tax credit for qualified investments in 'PPE manufacturing property.' This property must be tangible, depreciable, new or reconstructed, meet domestic content requirements (60% until 2028, then 75%), and be integral to a U.S.-based facility predominantly used for PPE production. This investment credit is an alternative to the production credit (manufacturers cannot claim both for the same facility). It also terminates after December 31, 2035.
This subsection defines 'domestic product.' For most medical consumables and non-textile PPE, it requires final assembly in the U.S. and a specific percentage of total component cost from domestic content (60% for the first three years of the program, increasing to 75% thereafter). For textile-based PPE (like masks, gowns, gloves), the definition is much stricter, requiring *each stage of production* and *each textile, fabric, or fiber* to be grown, reprocessed, reused, or produced in the United States.
Sec. 2, new Sec. 1866H(h)(1) of Social Security Act
Why it matters:While placing definitions in a dedicated section is standard legislative practice, the specific thresholds and the differentiated requirements for textile-based products are highly consequential for compliance and market impact, making their placement here a form of 'fine print'.
Case for: Proponents argue these specific and stringent definitions are critical to ensure that products truly contribute to domestic manufacturing and are not merely 'assembled' in the U.S. from foreign components. The higher standard for textiles reflects a desire for full supply chain control for these critical items.
Case against: Opponents might argue that the domestic content requirements, especially the 75% threshold and the 'each stage of production' rule for textiles, are extremely stringent and could be difficult or impossible for many manufacturers to meet initially, potentially limiting the availability of 'domestic products' and increasing costs for hospitals.
Estimated impact: This definition significantly impacts the feasibility and cost of compliance for manufacturers and hospitals, directly determining which products qualify for incentives and avoid penalties. It could reshape entire supply chains.
This sub-provision details how to calculate the 'total cost of components' for the domestic content requirement. For components purchased by the manufacturer, it includes acquisition costs, transportation, and any applicable tariffs or duties. For components manufactured by the same entity, it includes manufacturing costs (transportation, overhead) minus profit and final assembly cost.
Sec. 2, new Sec. 1866H(h)(1)(C) of Social Security Act
Why it matters:This is a necessary technical detail for the practical implementation of the domestic content rules, but its complexity makes it easy for a casual reader to overlook its significance.
Case for: Proponents argue that these detailed accounting rules provide clear, auditable standards for manufacturers to calculate domestic content, preventing loopholes and ensuring fair and consistent application of the incentives.
Case against: Opponents might argue that these intricate accounting requirements add significant administrative burden and complexity for manufacturers, especially smaller businesses, potentially deterring their participation in the domestic supply chain.
Estimated impact: This provision directly affects manufacturers' ability to comply with the domestic content rules and influences the overall cost of compliance, potentially requiring new internal accounting systems.
This subsection specifies the effective dates for the tax credit amendments. It states that the amendments apply to qualified personal protective equipment produced, and personal protective equipment manufacturing property placed in service, *after December 31, 2025*.
Sec. 4(d)
Why it matters:While effective dates are typically placed at the end of sections, the specific date here (retroactive to the bill's introduction date in September 2026) is highly significant for manufacturers and the federal budget, making it a key piece of fine print.
Case for: Proponents argue this provides an immediate incentive for manufacturers to begin or expand domestic production and investment, ensuring that the economic benefits of the credits are realized as quickly as possible, even before the bill's full enactment.
Case against: Opponents might argue that the retroactive application (given the bill's introduction in September 2026) could create administrative challenges for the IRS and businesses, or provide unintended windfalls for companies that already had plans in motion, rather than genuinely incentivizing new activity.
Estimated impact: This provision determines the immediate financial impact of the tax credits on manufacturers and the federal budget, influencing investment decisions made in the period leading up to the bill's potential passage.